Scientists at The Hospital for Sick Children (SickKids) have revealed a previously overlooked layer of genetic variation that ...

Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to ...

When we listen to a moving piece of music or feel the gentle pulse of a haptic vibration, our bodies react before we ...

Objectives To characterise the aetiological spectrum of thoracic granulomatous diseases and identify diagnostic features that facilitate differentiation among causes. Design Retrospective multicentre ...

Electricity use has surged in recent years, partly due to the need to power AI Data Centers. ‘Not Constitutional’: Trump Threatens Blue Slip Suit Shohei Ohtani faces unique MLB rule challenge in ...

A millennial woman who has been single for seven years has gone viral after sharing a heartbreaking realization she had, but the internet has responded in the most supportive way. Leila has spent most ...

I just counted my close friends. The ones I’d actually call if I needed help moving, or who I’d want to know if something truly important happened in my life. The number came to seven. Not 500 ...

Generative AI has had a less-than-stellar reception among the arts, with many speaking out against its use both to create art and be trained on the work of human creators. If you’re a fan of DC Comics ...

There are thousands of rare diseases, many so uncommon that patients never meet someone else with the same condition. More than half have no support network or advocacy group. That means being sick ...

President Donald Trump displays an executive order on artificial intelligence he signed at the "Winning the AI Race" AI Summit at the Andrew W. Mellon Auditorium in Washington, DC, on July 23, 2025.

We normally learn about the latest data center coming to South Carolina because Gov. Henry McMaster and the state Commerce Department boast about all the money they have enticed its owner to invest ...

ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...